1. Consensus on Medical Treatment of Metastatic Breast Cancer

   • Semir Beslija
   • Jacques Bonneterre
   • Heinz Zwierzina

   OriginalPaper Pages: 1 - 7

2. Which Treatment When?

   • P. Schmid
   • K. Possinger

   OriginalPaper Pages: 9 - 10

3. Efficacy of Combination Therapy Versus Monotherapy

   • Michael Krainer

   OriginalPaper Pages: 11 - 15

4. Role of Taxanes

   • Lubos Petruzelka

   OriginalPaper Pages: 17 - 24

5. The Role of Anthracyclines/Anthraquinones in Metastatic Breast Cancer

   • Semir Beslija

   OriginalPaper Pages: 25 - 32

6. Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer

   • Christoph C. Zielinski

   OriginalPaper Pages: 33 - 36

7. Chemotherapy of Metastatic Breast Cancer: Is more better?

   • Jacek Jassem

   OriginalPaper Pages: 37 - 42

8. Definition of An Optimal First-line Chemotherapy in Metastatic Breast Cancer

   • Volker Heinemann

   OriginalPaper Pages: 43 - 48

9. Chemotherapy for Advanced Breast Cancer – How Long Should it Continue?

   • Martin R Stockler
   • Nicholas JC Wilcken
   • Alan S Coates

   OriginalPaper Pages: 49 - 52

10. Chemotherapy or Endocrine Therapy for Metastatic Breast Cancer?

    • Nicholas Wilcken
    • Joanne Hornbuckle
    • Davina Ghersi

    OriginalPaper Pages: 53 - 56

11. Aromatase Inhibitors as First Line Treatment: Treatment Cascade After Failure of Aromatase Inhibitors

    • Jacques Bonneterre

    OriginalPaper Pages: 57 - 61

12. Testing to Define the Target Her-2/neu

    • Sylvie Menard

    OriginalPaper Pages: 63 - 66

13. Trastuzumab Monotherapy

    • Charles Vogel

    OriginalPaper Pages: 67 - 68

14. Trastuzumab in Combination with Chemotherapy

    • Harold J. Burstein

    OriginalPaper Pages: 69 - 72

15. Her-2/neu as Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer

    • Wolfgang J. Köstler
    • Christoph C. Zielinski

    OriginalPaper Pages: 73 - 84

16. Trastuzumab: How Long? Treatment Strategies after Failure

    • D.W. Miles

    OriginalPaper Pages: 85 - 86

17. Bisphosphonates in Metastatic Breast Cancer

    • Peter Schmid
    • Kurt Possinger

    OriginalPaper Pages: 87 - 93

18. The Role of Erythropoietin in the Supportive Care of Breast Cancer

    • Simon Van Belle

    OriginalPaper Pages: 95 - 97

19. Hormone Replacement Therapy after Breast Cancer?

    • Harold J. Burstein

    OriginalPaper Pages: 99 - 101

20. Psychosocial Support for Women with Advanced Breast Cancer

    • Pamela J. Goodwin

    OriginalPaper Pages: 103 - 110

21. High Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Breast Cancer: Is there a Place?

    • Edward A. Stadtmauer

    OriginalPaper Pages: 111 - 115

22. Future Directions in the Treatment of Metastatic Breast Cancer

    • H. Zwierzina
    • M. Gnant
    • Ch. Wiltschke

    OriginalPaper Pages: 117 - 118

23. Future Directions in the Treatment of Breast Cancer – Cellular Interventions Using Dendritic Cells

    • Michael F.X. Gnant
    • Peter C. Dubsky
    • Christoph C. Zielinski

    OriginalPaper Pages: 119 - 123